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Abstract 
Context: A mutation-specific phenotype is associated with the p.R63W mutation in the 
Hepatocyte nuclear factor (HNF)-4A gene. This includes macrosomia and atypical renal 
Fanconi syndrome, in addition to hyperinsulinaemic hypoglycaemia (HI) progressing into 
maturity-onset diabetes of the young (MODY). We describe 2 infants with additional features 
of this syndrome.  
Cases description: Patient 1, a male born at term with a birth weight of 3.99kg (95th centile, 
SDS 1.7), was diagnosed with HI on day two of life. He responded to 3mg/kg/day of 
Diazoxide, which was then discontinued 2 months later. Persistently raised serum creatinine 
led to investigation of renal tubular function showing leaking of calcium, magnesium, 
phosphate and protein. He had transient conjugated hyperbilirubinaemia with patchy 
liver steatosis on ultrasound.  Molecular analysis revealed a de novo p.R63W mutation in 
HNF4A.  
Patient 2 is a male born at 30+2 weeks with a weight of 1.53kg (64th centile, SDS 0.36). His 
mother had renal Fanconi syndrome. He received parenteral nutrition and first presented with 
hypoglycaemia at one month of age, while establishing enteral feeds. Biochemistry work-up 
showed low serum calcium, sodium, and phosphate concentrations, as a result of renal tubular 
leaking. Hypoglycaemia screen performed at 3 months of age documented HI and he was 
commenced on 2mg/kg/day of Diazoxide with good response.  He was heterozygote for a 
maternally inherited p.R63W mutation in HNF4A. A continue glucose monitoring performed 
in his mother revealed overnight hypoglycaemia.   
Conclusion: Renal Fanconi syndrome represents the only HNF4A feature showing complete 
penetrance. Our cases suggest that p.R63W HNF4A mutation must also be considered in 
subjects with normal birth weight and postulate the possibility of liver involvement as part of 
the condition.   
 
Context 
Congenital hyperinsulinism (CHI) is characterized by hypoglycaemia caused by unregulated 
insulin secretion from pancreatic beta-cells. So far, mutations in nine genes which control the 
insulin secretion (ABCC8, KCNJ11, GLUD1, GCK, HNF4A, HNF1A, SLC16A1, UCP2 and 
HADH) have been identified as a cause of CHI (1). However,                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
mutations in a single gene may be responsible for different phenotypes. Recent studies  
demonstrate that mutations in the hepatocyte nuclear factor (HNF)-4A, encoded by the 
HNF4A gene), initially reported in patients with maturity-onset diabetes of the young 
(MODY), may conversely cause CHI, with variable degree of severity (2,3). Recent reports 
(4,5) indicate a mutation-specific phenotype associated with the p.R63W mutation in the 
HNF4A gene, with macrosomic CHI and atypical Fanconi syndrome. We now extend the 
previous observations and present two patients with p.R63W mutation, one of them having a 
birth weight appropriate for his gestational age, the other having signs of liver involvement.  
 
Cases Description 
Case 1, a male was born at 38+2 weeks, with a weight of 3.99Kg (95th centile, SDS 1.7). On 
day two he presented with hypoglycaemic seizures (undetectable blood glucose). Initial 
investigations showed polycythaemia (Hb 26.2g/dl, Hct 76%), deranged renal function 
(creatinine 119umol/L (nr 37-93), Potassium 5.9mmol/L), conjugated hyperbilirubinaemia 
(146umol/L), metabolic acidosis (ph 7.3, PCO2 4.73kPa, HCO3 21.3mmol/L, BE 4.5mmol/L, 
Lactate 3.09mmol/L) and Staphylococcus Aureus sepsis. Despite response to antibiotics and 
resolution of polycythaemia, he continued having hypoglycaemia episodes, with a glucose 
requirement up to 18.9 mg/kg/min. Hypoglycaemia screen confirmed hyperinsulinism (Table 
1). He achieved stable blood glucose concentrations on 3mg/kg/day of Diazoxide. As a 
consequence of the persistently raised serum creatinine and high urine amino acids, he had a 
renal tubular screen done, showing features of renal Fanconi syndrome (Table 1). Abdomen 
ultrasound revealed normal kidneys and signs of patchy liver steatosis. Conjugated bilirubin 
normalized with ursodeoxycholic acid treatment.  He was heterozygote for the de novo 
c.187C>T (p.R63W) mutation in HNF4A. He is currently on 10mg/kg/day of Diazoxide and 
three-to-four hourly oral feeds, with stable blood glucose concentrations. 
 
Case 2, a male was born at 30+ 2 weeks by emergency caesarean section. Birth weight was 
1.53kg (64th centile, SDS 0.36). His mother had renal Fanconi syndrome, which was 
diagnosed at the age of two years, when she presented with rickets. On day one of life he was 
commenced on parenteral nutrition because of suspected necrotizing enterocolitis. While 
establishing enteral feeds, at the corrected age of 34 weeks, he presented with hypoglycaemia 
episodes (minimum blood glucose 1.6mmol/L). Echo showed small ventricular septal defect 
with left-to-right shunt. Biochemistry work-up at the time of hypoglycaemia confirmed 
hyperinsulinism and revealed low calcium, sodium, and phosphate concentrations. Renal 
tubular screen showed features of renal Fanconi syndrome, (Table 1). Ultrasound of the 
kidneys was normal. He has achieved good glycaemic control on 2mg/kg/day of Diazoxide 
and 3 hourly feeds. Molecular analysis showed a maternally inherited p.R63W mutation. 
Subsequent continue glucose monitoring performed on his mother (Figure 2) revealed 
prolonged overnight hypoglycaemia.   
 
Discussion 
Our clinical observations in these two patients expand the clinical phenotypes associated to 
HNF4A mutations. HNF4A mutation is the third commonest cause of Diazoxide-responsive 
CHI (1), usually associated with early presentation and macrosomia and MODY (3, 6). These 
phenotypes are not mutation-specific and a single mutation can cause opposite phenotypes in 
the same subject, according to the age. Furthermore, the penetrance of each phenotype is 
incomplete and thus, the absent history of neonatal hypoglycaemia in a subject with MODY 
or, on the other hand, the absence of any family history of diabetes in patients with CHI, does 
not exclude the diagnosis. A similar biphasic phenotype (hypoglycaemia – MODY) was 
initially described in patients carrying mutations in HNF1A (1), which is involved in the 
transcription of HNF4A through the pancreatic-specific promoter P2, and is in turn regulated 
by HNF4A (7). 
 
The HNF4A phenotypic spectrum has recently been expanded to include atypical renal 
Fanconi syndrome, specifically linked to the p.R63W mutation (4,5). Our cases provide 
further evidence of a mutation-specific renal phenotype and extend the previous observations, 
arising important clinical considerations.  
 
The molecular basis of renal Fanconi syndrome due to HNF4A mutations are far from clear, 
but seem to involve an impaired DNA binding. In fact, the R76 residue is in the DNA binding 
domain and its mutation affects charge and hydrophobicity in an area of intimate DNA 
contact. It has been hypothesized that this specific residue must be crucial in the renal 
proximal tubule (4, 5).  
 
Another possible explanation is to be sought into the intimate relationship between HNF4A, 
HNF1A and other regulatory proteins. Heterozygote knockout mice for either HNF4A or 
HNF1A have no distinct phenotype. On the contrary, although the homozygous knockout of 
HNF4A is lethal, mice with homozygous knockout of HNF1A (8) exhibit hepatic dysfunction, 
phenylketonuria and early onset renal Fanconi syndrome associated with raised urine 
calcium/creatinine ratio and reduced creatinine clearance.  
Given that HNF4A and HNF1A are involved in a feed-forward loop, it could be speculated 
that haploinsufficiency of HNF4A can impact on HNF1A, resulting in specific organ damage. 
Other genetic factors within the wide regulatory network of HNF4A are probably involved. 
Both HNF4A and HNF1A can regulate the expression of GLUT2 (SLC2A2), which is 
responsible, if mutated, for Fanconi-Bickel syndrome (9). Stanescu et al first reported a 
macrosomic female patient with Diazoxide-responsive CHI and atypical Fanconi syndrome 
due to a de novo p.R63W HNF4A mutation (described as p.R76W) (5), who also presented 
with liver involvement, thus mimicking Fanconi-Bickel syndrome. In this regard, it is worth 
noting that in case 1 from our case series, we observed prolonged conjugated 
hyperbilirubinaemia, which normalized over the first three months of life on ursodeoxycholic 
acid with patchy liver steatosis. In order to explain the clinical overlap between HNF4A 
mutation-specific phenotype and Fanconi-Bickel syndrome, a decreased expression of 
SLC2A2 either as a direct consequence of HNF4A impaired activity, or as a result of the 
impaired interaction between the mutant HNF4A with HNF1A, can be hypothesized (5). 
 
The absence of nephrocalcinosis in our cases compared to the others could be explained by 
the short follow-up. Similar to the other cases, our patients had high serum and urine 
magnesium concentrations, thus suggesting overflow rather than leaking as underlying cause 
of the high urine magnesium excretion (4).  
 Although all the cases previously reported with this specific mutation were born large for 
gestational age (10), interestingly case 2 from our cohort had a birth weight appropriate to his 
gestational age. Given that his mother has the same mutation and abnormal glycaemic profile, 
it is possible that in utero the fetus was exposed to blood glucose concentrations appropriate 
for his own set-point for insulin secretion, resulting in lower insulin concentrations. In 
addition prematurity and/or placental factors might have also have contributed.    
 
Conclusion 
Knowledge of the genetics of CHI allows prediction of disease progression and 
comorbidities. Atypical renal Fanconi syndrome represents the only HNF4A feature with 
complete penetrance, being present in all the patients reported carrying the p.R63W mutation. 
The underlying mechanisms are unclear and probably involve an impaired HNF4A regulatory 
network. Our cases suggest that HNF4A mutations must be considered also in the presence of 
a normal birth weight. Transient or permanent liver involvement may represent part of this 
condition and therefore awareness about the possibility of associated diseases is needed 
during follow-up of HNF4A–mutation carriers.  
 
 
 
 
 
  
 
 
 
 
 
Legends 
Table 1. Clinical and biochemical features of our patients 
Figure 1. Continuous glucose monitoring performed in the mother of Case 2. 
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 Table 1. Clinical and biochemical features of our patients.  
 Case 1 Case 2  
Gender 
 
Gestational age (weeks) 
Male 
 
38+2    
Male 
 
30+2 
 
    
Birth weight kg/SDS 3.99/1.7 1.530/0.36  
   Normal range 
Hypoglycaemia screen    
- Blood glucose mmol/L 
- Insulin mU/L 
- C-Peptide pmol/L 
- NEFA mmol/L 
- Ketones  mmol/L 
- Ammonia umol/L 
 
Urea, electrolytes and ALP 
- Urea mmol/L 
- Creatinine umol/L 
- Sodium mmol/L 
- Potassium mmol/L 
- Calcium mmol/L 
- Magnesium 
- Phosphate mmol/L 
- Alkaline phosphatase U/L 
2.5 
4.5 
233 
0.2 
0.06 
25 
 
 
1.1 
48 
143 
3.9 
2.6 
1.09 
1.82 
1069 
 
2.2 
6.3 
Not done 
0.36 
<0.05 
20 
 
 
1.4 
27 
140 
3.6 
2.27 
1.13 
1.39 
2730 
 
3.5-5.5 
 
 
 
 
<40 
 
 
0.7-5 
13-32 
133-146 
3.2-6 
2.17-2.44 
0.66-1 
1.2-2.1 
80-425 
 
Renal tubular screen (Urine)    
- Albumin/creatinine 
- RBP/creatinine 
82.5 
13647 
144 
44417 
1.7-12.2 
1.5-448 
- NAG/creatinine  
- Calcium/creatinine 
- Magnesium/creatinine 
- Phosphate/creatinine 
- TRP (%) 
549 
5.07 
2.5 
21.5 
52                          
1088 
5.6 
5.03 
32.12 
39 
2-27 
0.09-2.2 
0.4-2.2 
1.2-19 
70-100 
    
ALP alkaline phosphatase; RBP retinoid binding protein; NAG N-acetylglucosamine; TRP tubular 
reabsorption of phosphates 
 
 
 
 
Figure 1. Continuous glucose monitoring performed in the patient’s 2 mother (age 34.9 
years), showing wide variation of the blood glucose concentrations ranging from 2.2 to 14.3 
mmol/L (mean glucose 5.0 mmol/L). Prolonged overnight hypoglycaemia and post-prandial 
hyperglycaemia indicate a dysregulation in insulin secretion and action. 
 
 
